We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
Impact Health is a mission-driven health policy and strategic consulting firm dedicated to improving health and well-being for all.
OUR SERVICES
Strategic Planning
Integrate mission-aligned policy expertise and political acumen into planning and executing your goals.
Government Contracting
Track record of success supporting states and municipalities in innovating or launching new programs.
Our proprietary method for tracking, aggregating, and analyzing state policy trends.
If you believe that every American deserves to be healthy and well, contact Impact Health Policy Partners to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Impact Health Policy Partners, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Agency Proposes GLOBE Model, a Mandatory Medicare Part B Drug Pricing Model Using International Benchmarks; Comments Due February 21
The Centers for Medicare and Medicaid Services (CMS) released a Notice of Proposed Rulemaking (NPRM) for the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a mandatory model designed to reduce out-of-pocket costs for Medicare Part B beneficiaries and lower program expenditures by applying international pricing benchmarks to certain Part B drugs (CMMI Model Overview). The proposed GLOBE Model would… (Colocho, Eisen, December 19, 2025) #Drug Pricing, #Prescription Drugs
GUARD Model Proposed to Test Part D Inflation Rebate Changes Using International Reference Pricing; Comments Due February 21
Today, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule to implement the Guarding Against U.S. Medicare Against Drug Costs (GUARD) Model, which will test an alternative payment method for calculating Part D inflation rebates for certain drugs and biological products (press release). What is it. CMS proposes a new mandatory model that would test an alternative… (Slifer, December 19, 2025) #Medicare Part D, #Prescription Drugs